ELEVANCE HEALTH DL-,01/ US0367521038 /
| 2024-11-07 2:13:37 PM | Chg. -1.100 | Volume | Bid2:27:48 PM | Ask2:27:48 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 398.500EUR | -0.28% | 7 Turnover: 2,790.200 |
398.100Bid Size: 25 | 400.900Ask Size: 25 | 92.66 bill.EUR | - | - |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 2,735 | 3,133 | 3,483 | 3,919 | 4,316 | ||||||
| Intangible Assets | 9,007 | 8,674 | 9,405 | 10,615 | 10,315 | ||||||
| Long-Term Investments | 4,213 | 4,733 | 4,847 | 5,857 | 6,437 | ||||||
| Fixed Assets | 37,250 | 38,420 | 40,864 | 46,338 | 47,155 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 9,311 | 10,553 | 10,958 | 13,440 | 16,044 | ||||||
| Cash and Cash Equivalents | 3,934 | 4,937 | 5,741 | 4,880 | 7,387 | ||||||
| Current Assets | 34,321 | 39,033 | 45,751 | 51,122 | 55,617 | ||||||
| Total Assets | 71,571 | 77,453 | 86,615 | 97,460 | 102,755 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 12,413 | 13,040 | 16,852 | 18,488 | 21,203 | ||||||
| Long-term debt | 17,217 | 17,787 | 19,335 | 21,157 | 22,349 | ||||||
| Liabilities to Banks | 1,145 | 700 | 0.0000 | 275 | - | ||||||
| Provisions | 2,666 | 2,901 | 2,019 | 2,805 | - | ||||||
| Liabilities | 43,030 | 45,725 | 53,416 | 61,332 | 66,425 | ||||||
| Share Capital | 3 | 3 | 3 | 2 | 2 | ||||||
| Total Equity | 28,541 | 31,728 | 33,199 | 36,128 | 36,330 | ||||||
| Minority Interests | - | - | - | 68 | 87 | ||||||
| Total liabilities equity | 71,571 | 77,453 | 86,615 | 97,460 | 102,755 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 92,105 | 104,213 | 121,867 | 138,639 | 156,595 | ||||||
| Depreciation (total) | 358 | 338 | 361 | 441 | 767 | ||||||
| Operating Result | 5,426 | 5,999 | 6,360 | 7,489 | 8,283 | ||||||
| Interest Income | -753 | -746 | -784 | -798 | -851 | ||||||
| Income Before Taxes | 5,068 | 5,985 | 6,238 | 7,925 | 7,769 | ||||||
| Income Taxes | 1,318 | 1,178 | 1,666 | 1,830 | 1,750 | ||||||
| Minority Interests Profit | - | - | - | 9 | 6 | ||||||
| Net Income | 3,750 | 4,807 | 4,572 | 6,104 | 6,025 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 3,827 | 6,061 | 10,688 | 8,364 | 8,399 | ||||||
| Cash Flow from Investing Activities | -1,259 | -2,792 | -7,324 | -9,638 | -4,560 | ||||||
| Cash Flow from Financing | -2,241 | -2,266 | -2,567 | 423 | -1,318 | ||||||
| Decrease / Increase in Cash | 325 | 1,003 | 804 | -861 | 2,507 | ||||||
| Employees | 63,900 | 70,600 | 83,400 | 98,200 | - | ||||||
